Results 131 to 140 of about 13,171 (198)

Efficacy and safety of venanprubart, a BTLA agonist antibody, in patients with active systemic lupus erythematosus. [PDF]

EULAR Rheumatol Open
Ghosh I, Sweeney SE, Moser B, Ferrante A, Witcher JW, Munoz-Briones J, Chang CY, Linnik MD, Vendel AC.   +8 more
europepmc   +1 more source

Hvem gavner hvem i marken?

, 2008
Eilenberg, Jørgen, Jensen, Annette Bruun, Meyling, Nicolai Vitt   +2 more
openaire   +1 more source

Analysis of Immune Checkpoints on Peripheral Blood Mononuclear Cells Can Predict Clinical Outcome and Reveal Potential of HVEM-BTLA Axis in Epithelial Ovarian Cancers. [PDF]

Pharmaceuticals (Basel)
Lai YL, Lin HW, Huang YW, Chen J, Tai MC, Wu CY, Yang TS, Oblin V, Shea K, Chen YL.   +9 more
europepmc   +1 more source

Pan-Cancer Landscape of B- and T-Lymphocyte Attenuator: Implications for Potential Immunotherapy Combinations. [PDF]

JCO Precis Oncol
Nishizaki D, Choi S, Pandya C, Lee S, Pabla S, DePietro P, Jensen TJ, Kurzrock R, Kato S.   +8 more
europepmc   +1 more source

Antagonistic co-evolution throughout the herpesvirus life cycle. [PDF]

Virus Evol
Höfler T, Abdulrahman DA, Reich J, Kossak L, Ospina-Garcia J, Serdar DG, Nascimento MM, Cheng Y, Kaufer BB, Trimpert J.   +9 more
europepmc   +1 more source

Design, synthesis, and anti-inflammatory evaluation of new isatin azo disperse dyes: computational studies, molecular docking, and printing performance on polyester fabrics. [PDF]

RSC Adv
Hekal HA, Shaban E, Elshahid ZA, Abd El Salam HA, Atlam FM, Nosier AA.   +5 more
europepmc   +1 more source

Keratinocyte Priming by Staphylococcus aureus Reduces HSV-1 Susceptibility. [PDF]

Allergy
Baumann PC, Pospich R, Döhner K, Klug I, Guerrero JCV, Hartmann J, Harder I, Lieb W, Kind B, Kleinheinz A, Abraham S, Augustin M, Weisshaar E, Schmitt J, Weidinger S, Sodeik B, Werfel T, Roesner LM, Traidl S, TREATgermany Study Group.   +19 more
europepmc   +1 more source

Pleiotropic and multicellular roles of lymphotoxin beta receptor in solid tumor immunity and therapeutic targeting. [PDF]

Front Immunol
Anshu, Shantikumar V N, Sreeja R.
europepmc   +1 more source

Chemoradiation of glioblastoma cells alters expression of activation and immune checkpoint molecules on type 1 and 2 dendritic cells and impacts on subsequent T cell proliferation. [PDF]

Clin Transl Radiat Oncol
Schuster C, Frey B, Fietkau R, Corradini S, Gaipl US, Derer A.   +5 more
europepmc   +1 more source

Integration of Circulating Immune Checkpoint Proteins and Osteopontin Refined Risk Stratification in Osteosarcoma. [PDF]

Cancers (Basel)
Sang NTQ, Khanh NV, Hai H, Dung TT, Thanh TD, Quang DM, Anh PT, Chi NBT, Bao TV, Trung NV, Hien TTT, Terai H, Thuy LTT.   +12 more
europepmc   +1 more source